Merck Views Rx/Dx Partnerships as 'Method for Success' in Recession, Company Official Says

In recent years, "I have been involved in product licensing, but I have also increasingly become involved in Rx/Dx partnerships," Cynthia Gawron-Burke, director of external scientific affairs at Merck, said at a conference.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.